Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Pereira De Matos Cordeiro (Torres Vedras, Portugal), A. Nunes (Torres Vedras, Portugal), C. Rolo (Torres Vedras, Portugal), D. Duarte (Torres Vedras, Portugal), N. André (Torres Vedras, Portugal), R. Macedo (Lisboa, Portugal), A. Domingos (Torres Vedras, Portugal). An outbreak of extensively drug-resistant tuberculosis among a Portuguese family. 469

Member's Comments

No comment yet.

Related content which might interest you: Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city Source: Eur Respir J 2013; 41: 901-908 Year: 2013 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 870-872 Year: 2013 A case of resistance beyond extensively drug-resistant tuberculosis in Japan Source: Eur Respir J 2013; 42: 872-873 Year: 2013 Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Multidrug- and extensively drug-resistant tuberculosis: an emerging threat Source: Eur Respir Rev 2009; 18: 195-197 Year: 2009 Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007 Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021 Year: 2022 Risk factors for treatment failure in multidrug-resistant and extensively drug-resistant tuberculosis in Estonia Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009–2016 Source: Eur Respir J, 52 (1) 1800070; 10.1183/13993003.00070-2018 Year: 2018 Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Epidemiology of TB Source: Eur Respir Mon 2012; 58: 14-25 Year: 2012 Treating extensively drug resistant tuberculosis (XDR-TB) in India Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB Source: Eur Respir J 2009; 33: 1085-1094 Year: 2009 High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014 Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR) mycobacterium tuberculosis strains in clinical practice Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008